Tech Company Financing Transactions

TCR2 Therapeutics Funding Round

TCR2 Therapeutics, based in Cambridge, raised $125 million from 6 Dimensions Capital, Alexandria Venture Investments and ArrowMark Partners.

Transaction Overview

Company Name
Announced On
3/22/2018
Transaction Type
Venture Equity
Amount
$125,000,000
Round
Series B
Proceeds Purpose
Proceeds of the financing will be used to advance two TRuC-T cell programs through human proof-of-concept, including its lead solid tumor program TC-210 targeting mesothelin.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Binney St. 710
Cambridge, MA 02142
USA
Email Address
Overview
TCR2, Inc. (Nasdaq: TCRR) is a pharmaceutical company focused on engineering T cells for cancer therapy.
Profile
TCR2 Therapeutics LinkedIn Company Profile
Social Media
TCR2 Therapeutics Company Twitter Account
Company News
TCR2 Therapeutics News
Facebook
TCR2 Therapeutics on Facebook
YouTube
TCR2 Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Garry Menzel
  Garry Menzel LinkedIn Profile  Garry Menzel Twitter Account  Garry Menzel News  Garry Menzel on Facebook
Chief Financial Officer
Ian Somaiya
  Ian Somaiya LinkedIn Profile  Ian Somaiya Twitter Account  Ian Somaiya News  Ian Somaiya on Facebook
Chief Medical Officer
Alfonso Cardama
  Alfonso Cardama LinkedIn Profile  Alfonso Cardama Twitter Account  Alfonso Cardama News  Alfonso Cardama on Facebook
Chief Scientific Officer
Robert Hofmeister
  Robert Hofmeister LinkedIn Profile  Robert Hofmeister Twitter Account  Robert Hofmeister News  Robert Hofmeister on Facebook
VP - Bus. Development
Andrew Cornforth
  Andrew Cornforth LinkedIn Profile  Andrew Cornforth Twitter Account  Andrew Cornforth News  Andrew Cornforth on Facebook
VP - Operations
Amy Lynch
  Amy Lynch LinkedIn Profile  Amy Lynch Twitter Account  Amy Lynch News  Amy Lynch on Facebook
VP - R & D
Daniel Getts
  Daniel Getts LinkedIn Profile  Daniel Getts Twitter Account  Daniel Getts News  Daniel Getts on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/22/2018: Mamava venture capital transaction
Next: 3/22/2018: Align venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary